Back to results list
Please use this identifier to cite or link to this item:
|Title:||Ghrelin axis reveals the interacting influence of central obesity and hypertension||Authors:||Yu, AP
|Issue Date:||2018||Publisher:||Frontiers Research Foundation||Source:||Frontiers in Endocrinology, 2018, v. 9, no. SEP, 534 How to cite?||Journal:||Frontiers in Endocrinology||Abstract:||Objective: This study aimed to investigate how central obesity and hypertension modulate unacylated ghrelin (UnAG), acylated ghrelin (AG), obestatin, growth hormone (GH), and the ratios of UnAG/obestatin, AG/obestatin, and total ghrelin/obestatin.
Methods: Circulatory abundances of UnAG, AG, obestatin and GH were determined in 387 Hong Kong Chinese female adults with age between 24 to 86 years based on a 2 × 2 factorial design of hypertension (blood pressure ≥140/90 mmHg) and central obesity (waist circumference or WC ≥80 cm). Participants were categorized as neither hypertensive nor centrally obese (NHNO; n = 105), hypertensive but not centrally obese (HNO; n = 102), centrally obese but not hypertensive (NHO; n = 74) and hypertensive and centrally obese (NO; n = 106). Pearson's correlation analyses were performed to detect the association between the peptides examined with WC and blood pressure. The main and interaction effects of hypertension and central obesity were examined by generalized estimating equations analyses.
Results: Correlation analyses revealed that systolic blood pressure was negatively correlated with AG/obestatin, UnAG/obestatin and total ghrelin/obestatin ratios, AG, total ghrelin, and GH, while diastolic blood pressure was negatively correlated with UnAG/obestatin, total ghrelin/obestatin ratios, and GH. WC was negatively correlated with AG/obestatin, UnAG/obestatin, and total ghrelin/obestatin ratios, UnAG, AG, total ghrelin, GH, and obestatin. Interaction effects of hypertension and central obesity were observed on UnAG/obestatin, AG/obestatin and total ghrelin/obestatin ratios, and obestatin. Obestatin in NHO group was significantly higher compared to NHNO and HO groups. UnAG/obestatin, AG/obestatin, and total ghrelin/obestatin ratios were higher in NHNO group compared to HNO and HO groups. Main effects of central obesity and hypertension were observed in UnAG, total ghrelin and GH. The HO group manifested the lowest level of UnAG, total ghrelin and GH among all the groups studied. Main effect of hypertension was observed on AG, suggesting that hypertensive individuals exhibited lower levels of AG regardless of central obesity.
Conclusion: Circulatory ghrelin gene products and GH exhibit different modes of modulation in response to the co-manifestation of multiple cardiovascular risk factors compared with a single risk factor alone.
|URI:||http://hdl.handle.net/10397/80390||EISSN:||1664-2392||DOI:||10.3389/fendo.2018.00534||Rights:||Copyright © 2018 Yu, Ugwu, Tam, Lee, Lai, Wong, Lam, Sheridan and Siu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
The following publication: Angus, P. Y., Ugwu, F. N., Tam, B. T., Lee, P. H., Lai, C. W., Wong, C. S., & Siu, P. M. (2018). Ghrelin axis reveals the interacting influence of central obesity and hypertension. Frontiers in Endocrinology, 9 is available at https://doi.org/10.3389/fendo.2018.00534
|Appears in Collections:||Journal/Magazine Article|
Show full item record
Files in This Item:
|Yu_Ghrelin_axis_reveals.pdf||2.38 MB||Adobe PDF||View/Open|
Citations as of Mar 22, 2019
Citations as of Mar 22, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.